Home » Topics » Regulatory

Regulatory
RSS

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

Alferon N Injection completes phase III in HIV

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Alza and Warner-Lambert sign distribution agreement for nasal decongestant OTC

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Propecia recommended for approval for hair loss in men

Dec. 9, 1997

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...